What Is a Green Shoe Option in an IPO? How It Stabilises Price

A green shoe option in an IPO is a price-stabilising tool: it lets the issuer allot up to 15% more shares than the base offer and use the extra money to support the stock if it drops after listing. Run by a stabilising agent under SEBI’s ICDR Regulations, it cushions early volatility — it does not guarantee the price.

That one-line answer hides a surprising amount of machinery — borrowed promoter shares, a special bank account, daily exchange filings, and a 30-day clock. It also raises an obvious question: if this mechanism exists to protect listing-day investors, why do so few Indian IPOs actually use it? If you want to read offer documents and listing mechanics with real confidence rather than guesswork, a structured stock market course turns scattered terms like this into a working mental model.

What problem does a green shoe option actually solve?

When a company lists, the first few days of trading are the most fragile stretch of its public life. The issue price was set by the book-building process before anyone could trade the stock; the moment it lists, thousands of fresh shareholders — including investors who only wanted the listing-day pop — can hit the sell button at once. If that selling overwhelms genuine demand, the price can slide well below the issue price on day one, which rattles retail investors and dents the issuer’s reputation just when it matters most.

The green shoe option is the regulated answer to that specific risk. Named after the Green Shoe Manufacturing Company, which first used the structure in the United States, it gives the issuer a controlled way to meet excess demand and defend the price during the fragile early window without quietly propping up a stock behind the scenes. Everything happens inside a framework SEBI lays down, with disclosure in the offer document, a named agent, and a hard time limit.

India adopted the mechanism in August 2003 through an amendment to the then-governing SEBI (Disclosure and Investor Protection) Guidelines, 2000. Today it sits in Regulation 57 of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 — commonly shortened to the SEBI ICDR Regulations. The core promise is modest and honest: the option is a shock absorber for temporary downward pressure, not a price guarantee. If the market genuinely values the company below its issue price, no stabilising agent can — or is allowed to — hold the price up forever.

It helps to separate the green shoe option from two things it is often confused with. It is not the same as how the issue price itself is decided; that happens earlier, in the way we covered in book building versus fixed-price IPOs. And it is separate from the demand signal sent by large institutions — the role played by anchor investors who commit before the IPO opens. The green shoe is purely a post-listing stabilisation device.

How does the green shoe mechanism work, step by step?

The mechanism looks complicated, but it follows a clean sequence. Before the issue opens, the issuer signs a pre-issue agreement with an existing shareholder — usually a promoter — who agrees to lend shares for stabilisation. The issuer also appoints a stabilising agent, drawn from the merchant bankers or book-running lead managers to the issue. These arrangements, and the intention to use a green shoe, are disclosed up front in the offer document, so nothing about the process is hidden from investors.

Here is the lifecycle at a glance:

Because the agent allotted more shares than the company actually issued, it starts the listing in a short position: it owes those borrowed shares back to the promoter. The money collected from the over-allotment sits in a dedicated green shoe bank account, ring-fenced from the issuer’s regular proceeds. How that short position is closed — by buying shares in the market or by the company issuing brand-new ones — depends entirely on what the price does after listing. That is the heart of the mechanism, and it is worth walking through both paths carefully.

Two details matter for the structure’s integrity. First, the over-allotment is capped at 15% of the issue size, so stabilisation can never become a back-door way to flood the market with shares. Second, the stabilising agent cannot keep a profit from the exercise — a rule that shapes the incentives in a way most investors never notice, and that we will return to below.

What happens if the price falls — or rises — after listing?

Everything in the green shoe mechanism comes down to a single fork in the road during the stabilisation window. The stabilising agent is holding the money from the over-allotted shares and owes real shares back to the promoter. What it does next depends only on where the market price sits relative to the issue price.

If the price falls below the issue price, the agent steps into the market as a buyer. It uses the cash parked in the green shoe account to buy shares at the depressed price, which adds demand and helps arrest the slide. Those purchased shares are then handed back to the promoter who lent them. Because the agent bought at a lower price than it sold during the over-allotment, there is usually a surplus — and that surplus is exactly where SEBI’s profit rule bites.

If the price holds or rises, there is no point buying shares in the open market — they are expensive, and the stock does not need defending. Instead, the issuer simply issues fresh shares equal to the over-allotment and gives those to the promoter to settle the loan. This is what it means to “exercise” the green shoe option: the company’s share count and capital raised both increase by up to 15%, reflecting the genuine extra demand.

A quick comparison makes the two paths concrete:

Notice what the surplus rule does. Under Regulation 57, any money left in the green shoe account after stabilisation — the gain from buying low and over-allotting higher — does not go to the agent, the issuer or the promoter. It is transferred to the Investor Protection and Education Fund. The stabilising agent earns a fixed fee for the job and nothing more, which is a deliberate design choice: it removes the temptation to manipulate the price for profit.

Why do so few Indian IPOs use the green shoe option?

Given how neatly the mechanism protects listing-day investors, newcomers are often surprised that most Indian IPOs skip it. The reasons are practical rather than regulatory, and they are worth understanding because they reveal how the real world weighs costs against benefits.

• The outcome is uncertain. The 15% cap and the 30-day window are finite. If selling pressure is heavy and persistent, the agent can exhaust its firepower before the market settles, and the price slips anyway. Issuers are reluctant to pay for a shield that may not hold.
• It is seen as interfering with price discovery. Some market participants argue that letting an agent buy to prop up a newly listed stock distorts the genuine supply-and-demand signal that a listing is supposed to reveal.
• The compliance burden is heavy. Running a green shoe means a separate bank account, daily reporting of stabilisation trades to the exchanges, strict timelines for returning borrowed shares, SEBI reporting and detailed legal documentation — real cost and effort for the issuer and the agent.
• No profit, full risk for the agent. Because any stabilisation surplus goes to the Investor Protection and Education Fund, the agent must do the buying if prices fall but keeps only a fixed fee. The risk-reward is lopsided, so merchant bankers rarely push for it.

The net effect: the green shoe is a well-designed tool that the commercial maths quietly discourages. Tata Consultancy Services became the first Indian company to use the mechanism back in 2004, and a handful of large issuers have used it since, but it has never become standard practice. For most issuers, the honest calculation is that the mechanism costs more certainty and compliance than the protection it offers is worth. Whether a company reserves a green shoe tends to depend on how it raises money overall — a theme that connects to how IPO subscription categories like QIB, NII and retail work.

What should an IPO investor take away from this?

For an everyday investor, the green shoe option is not a reason to apply for an IPO or to skip one. It is context — a signal of how the issue is structured and a reminder of what listing-day price action does and does not mean. If an offer document mentions a green shoe, you now know there is a mechanism that may soften early volatility for up to 30 days, funded by over-allotment and run by a named agent under clear rules.

Crucially, a green shoe does not promise a listing gain, and its absence does not doom an issue. The far more useful habit is to read the offer document for the things that actually drive long-term value — the business, the use of proceeds, the valuation and the risks — rather than treating any single structural feature as a buy or sell signal. That reading skill is learnable, and it compounds across every IPO you ever evaluate.

Frequently Asked Questions

What does “green shoe” mean in simple terms?

Green shoe is the nickname for an over-allotment option. It lets an IPO issuer sell up to 15% more shares than planned and then, through a stabilising agent, either buy shares back if the price falls or issue the extra shares if demand is strong. The name comes from the first US company to use the structure, Green Shoe Manufacturing.

How long does the price stabilisation last?

The stabilisation window runs for up to 30 days from listing. Within that period the stabilising agent can buy shares in the open market to support the price. Once the window closes, or once the entire over-allotment has been bought back, the green shoe account is settled and the mechanism ends. There is no stabilisation after the window.

Does a green shoe option guarantee the IPO price will not fall?

No. A green shoe option is a cushion for temporary downward pressure, not a guarantee. The agent’s buying power is capped at 15% of the issue and lasts only 30 days. If the market genuinely values the company below its issue price, the stabilisation mechanism cannot — and is not meant to — hold the price up indefinitely.

Who runs the stabilisation and who keeps the profit?

A stabilising agent, appointed from the issue’s merchant bankers, runs the process. It borrows shares from a promoter before the issue and returns them afterwards. Under Regulation 57 of the SEBI ICDR Regulations, any surplus from stabilisation goes to the Investor Protection and Education Fund — the agent earns only a fixed fee.

Why do most Indian IPOs not have a green shoe option?

Because the costs often outweigh the benefit. The 15% cap and 30-day window may not be enough in a heavy sell-off, the compliance work is substantial, and the agent carries the buying risk while any surplus goes to a public fund. So most issuers decide the mechanism is not worth the added certainty and effort, and it remains uncommon.

Disclaimer: This article is for educational purposes only and does not constitute investment advice. Markets carry risk — please do your own research or consult a qualified financial professional before investing. NIFM provides training and exam preparation; certification exams conducted by regulatory or professional bodies are administered by those bodies independently.